Thomson Reuters Releases iPhone Support for Clinical Xpert Navigator

News provided by

Oct 20, 2010, 10:50 ET

ANN ARBOR, Mich., Oct. 20 /PRNewswire/ -- Thomson Reuters, a global provider of information for healthcare professionals, has released the newest version of its award-winning Clinical Xpert Navigator mobile clinical data application.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090507/NY12658LOGO )

(Logo: http://photos.prnewswire.com/prnh/20090507/NY12658LOGO )

The new version allows hospital-based clinicians to access complete patient clinical data — including laboratory results, medications, vital signs, observations, transcribed reports, demographics, and more via their iPhone®, iPod touch®, and iPad™ devices.

A demonstration of the new functionality is available at clinicalxpert.com/iphone.

"Bringing Navigator to the iPhone is a great enhancement to a product that has helped us clinically for years, " said Bryce Strohbehn, system consultant at The Nebraska Medical Center in Omaha, Nebraska. "When our doctors saw the extent of the patient information that they could access in real-time they were very eager to start using it.

"The existing Clinical Xpert interface was already intuitive and easy to use, but this latest iPhone functionality now makes it even easier to quickly find the patient data our clinicians need."

Clinical Xpert aggregates real-time data feeds from disparate hospital information systems and creates a single patient record. This patient information is then pushed out to different applications for clinicians via the Web and mobile devices.

Clinical Xpert can be quickly integrated within any hospital IT environment — including hospitals using platforms from Cerner, Eclipsys, Epic, GE, MEDITECH, McKesson and Siemens. In just a few weeks, hospital clinicians can begin accessing their real-time patient data anytime, anywhere.

"Clinical Xpert is an excellent organizer and time saver. I can get the information I need about my patients anytime I need it — at their bedside, in my office or in a restaurant," said Dr. Steven Black, a surgeon at The Nebraska Medical Center. "If I order lab work on the weekend, I can get the results when I'm out with my family at the park. It would be hard to give up this application."

Clinical Xpert has been a leader in providing mobile patient data to hospital clinicians for over ten years. With this latest enhancement, it now supports more mobile platforms than any other mobile data vendor. In addition to supporting clinicians using the iPhone, iPod touch, and iPad devices, Clinical Xpert also supports BlackBerry, Windows Mobile and Palm mobile platforms.

The Clinical Xpert suite of workflow solutions includes Navigator for rounding physicians, CareFocus for real-time clinical surveillance, Billing for recording charges for clinical procedures performed in the hospital, and Pharmacy Xpert for more efficiently managing the hospital pharmacists' medication therapy.

"This iPhone release represents the continued evolution of the Clinical Xpert suite. It is our latest advancement in delivering intelligent evidence to hospital clinicians," said Thomas Hegelund, executive vice president at Thomson Reuters. "By combining real-time clinical data with evidence-based reference content directly at the point of care, we are helping clinicians work more efficiently, deliver high quality care and reduce the overall cost of treatment."

Visit clinicalxpert.com for more information.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs 55,000 people and operates in over 100 countries. For more information, go to www.thomsonreuters.com.

SOURCE Thomson Reuters